IPO Boutique

Kailera Therapeutics, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Kailera Therapeutics, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Kailera Therapeutics, Inc.KLRA -
NASDAQ
$14.00-$16.00 $16.00 $26.0039.1 million4/17/2026
J.P. Morgan, Leerink Partners, TD Cowen, Evercore ISI
Co-Manager(s):
William Blair
Health Care
Filing(s):

Filed 2026-03-27
Terms Added 2026-04-13



Kailera Therapeutics, Inc. Quote & Chart - Click for current quote - KLRA

About Kailera Therapeutics, Inc. (adapted from Kailera Therapeutics, Inc. prospectus):
They are an advanced clinical-stage biotechnology company focused on elevating the next era of obesity care by advancing a diversified pipeline to provide options for people living with obesity no matter where they are in their treatment journey.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "KLRA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2026 IPO Boutique. All Rights Reserved